NCT06738498Recruiting
Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction Outcomes
The Impact of Pre-Hospital and Hospital Delays on Myocardial Infarction Outcomes: A Prospective Study
Source: ClinicalTrials.gov · Last updated 17 Sept 2026
Brief summary (registry, in English)
The goal of this prospective observational study is to investigate the impact of pre-hospital and hospital delays on the outcomes of myocardial infarction (MI) patients admitted to Al-Kadhimiya Teaching Hospital, Baghdad. The main questions it aims to answer are: How do pre-hospital delays (e.g., patient transport and first medical contact) affect clinical outcomes such as mortality, complication rates, and recovery time in MI patients? What is the influence of hospital-related delays (e.g., time to intervention or reperfusion therapy) on the prognosis of MI patients? Participants will: Be monitored for the time elapsed from symptom onset to first medical contact and subsequent time intervals during hospital care. Have their clinical outcomes, including in-hospital mortality, length of stay, and post-intervention complications, recorded and analyzed.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 13 Dec 2024
- Start date
- 20 Feb 2025
- Primary completion date
- 10 Dec 2027
- Lead sponsor
- Al-Nahrain University
- Diseases
- Coronary artery disease
- NCT number
- NCT06738498
What you commit to
- Study type: Observational
- Planned participants: 200
- From 20 Feb 2025 to the primary completion date, 10 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with non-acute myocardial infarction (e.g., stable angina, prior MI).
- Patients who are transferred to another facility before reperfusion therapy is initiated.
Other illness
- Patients with severe comorbidities (e.g., advanced cancer, end-stage renal disease) that may complicate outcome assessments or interfere with treatment protocols.
Other
- Pregnant women or breastfeeding women.
Who the study is looking for
- Patients who provide informed consent (or a legal representative provides consent if the patient is unable to do so).
- Patients who undergo reperfusion therapy, such as thrombolysis or percutaneous coronary intervention (PCI).
- Patients admitted to Al-Kadhimiya Teaching Hospital within 12 hours of symptom onset.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| College of Medicine - Al-Nahrain University Coordinator of this site? Confirm its status | Baghdad | Iraq | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.